Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 27,114 |
|
|||||
| News | - | ||||||
| Day High | 13.27 | Low High |
|||||
| Day Low | 12.40 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Greenwich LifeSciences Inc | GLSI | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.27 | 2.13% | 12.96 | 13:21:01 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 12.59 | 12.40 | 13.27 | 12.69 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 565 | 27,114 | $ 12.88 | $ 349,315 | - | 7.58 - 21.44 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 13:23:27 | 1 | $ 12.77 | USD |
Greenwich LifeSciences Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 166.51M | 12.85M | - | 0 | -7.83M | -0.61 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Greenwich LifeSciences News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical GLSI Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 14.27 | 14.70 | 11.375 | 12.83 | 39,290 | -1.31 | -9.18% |
| 1 Month | 19.90 | 21.44 | 11.375 | 16.14 | 38,473 | -6.94 | -34.87% |
| 3 Months | 9.13 | 21.44 | 8.00 | 14.41 | 54,175 | 3.83 | 41.95% |
| 6 Months | 8.16 | 21.44 | 7.58 | 13.25 | 34,527 | 4.80 | 58.82% |
| 1 Year | 11.50 | 21.44 | 7.58 | 12.16 | 26,524 | 1.46 | 12.70% |
| 3 Years | 36.69 | 48.96 | 6.8241 | 18.47 | 70,823 | -23.73 | -64.68% |
| 5 Years | 5.00 | 158.07 | 3.262 | 36.98 | 163,373 | 7.96 | 159.20% |
Greenwich LifeSciences Description
| Greenwich LifeSciences Inc is a biopharmaceutical company that is developing GP2, an immunotherapy designed to prevent the recurrence of breast cancer following surgery. GP2 is a 9 amino acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers, including expression in most breast cancers at low, intermediate, and high or overexpressor levels. |
